Baiyunshan released its first half of 2017 performance report on August 20. From January to June 2017, Guangyao Baiyunshan achieved operating income of RMB 11,115,388,000, a year-on-year increase of 2.38%; total profit was RMB 1,400,428,000, an increase of 32.22 %; net profit attributable to shareholders of listed companies was RMB 1,158,140,000, an increase of 39.23% over the same period last year.
In the first half of the year, Guangyao Baiyunshan actively promoted the development of the four business segments of “Da Nan Pharmaceutical, Great Health, Big Business, and Great Medical Care â€, vigorously promoted the strategic upgrade of the four major sectors, increased marketing and marketing efforts, and strived to improve quality. benefit.
Disease Test Adenovirus Rapid Test Kit
Pathological Analysis Equipments
Disease Test Adenovirus Rapid Test Kit
NINGBO AUTRENDS INTERNATIONAL TRADE CO., LTD , https://www.metests.com